Iain D. Dukes - 12 Dec 2025 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
Chief Executive Officer, Director
Signature
/s/ Iain Dukes
Issuer symbol
TRAW
Transactions as of
12 Dec 2025
Net transactions value
$0
Form type
4
Filing time
16 Dec 2025, 18:17:27 UTC
Previous filing
15 Oct 2025
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dukes Iain D. Chief Executive Officer, Director C/O TRAWS PHARMA, INC., 12 PENNS TRAIL, NEWTOWN /s/ Iain Dukes 16 Dec 2025 0001681955

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRAW Common Stock Award $0 +36,943 +28% $0.000000 171,130 12 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Stock Option (right to purchase) Award $0 +147,771 $0.000000 147,771 12 Dec 2025 Common Stock 147,771 $2.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis.
F2 The options vest 100% on the first anniversary of the grant date.